期刊文献+

冠心病患者外周血内皮祖细胞数量和功能的变化 被引量:3

Changes in the number and activity of endothelial progenitor cells from peripheral blood in patients with coronary artery diseases
原文传递
导出
摘要 目的 :观察冠心病 (CHD)患者外周血内皮祖细胞 (endothelialprogenitorcells,EPC)数量和功能的改变。方法 :选择CHD患者和非CHD患者各 2 0例 ,用密度梯度离心法从外周血获取单个核细胞 ,将其接种在人纤维连接蛋白包被培养板 ,培养 7d后贴壁细胞进行细胞化学分析。激光共聚焦显微镜鉴定FITC标记荆豆凝血素Ⅰ和DiI 标记的乙酰化低密度脂蛋白双染色阳性细胞为正在分化的EPC。采用二苯基四氮唑嗅盐比色法、改良的Boyden小室和黏附能力测定实验观察EPC的增殖能力、迁移能力和黏附能力。 结果 :CHD患者外周血EPC数量明显减少 [(31.8± 7.7)∶(5 9.5± 10 .6 )EPC/视野 (× 2 0 0 ) ,P <0 .0 5 ],且CHD患者外周血EPC的黏附能力、迁移能力和增殖能力也明显受损。结论 :CHD患者外周血EPC数量减少、功能减退。 Objective:To investigate changes in the number and activity of endothelial progenitor cells(EPC) from peripheral blood in patients with coronary artery diseases.Method:EPCs were isolated from patients with coronary heart disease(CHD,n=20) and age-matched control subjects (n=20). EPC were characterized as adherent cells double positive for DiL-acLDL-uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. EPC proliferation and migration were assayed by MTT assay and modified Boyden chamber assay, respectively. EPC adhesion assay was performed by replating those on fibronectin-coated dishes, then adherent cells were counted.Result:The number of EPC was significantly reduced in subjects with CAD compared with that of age-matched control subjects ( 31.8± 7.7)∶( 59.5± 10.6)EPC/×200 field; P< 0.05). In ad- dition, the functional activity of EPCs such as proliferative, migratory and adhesive capacity was also impaired in patients with CAD.Conclusion:It is suggested that a novel pathophysiological mechanism of CAD may be defined: the reduction of EPCs with decreased functional activity.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2004年第3期145-147,共3页 Journal of Clinical Cardiology
基金 浙江省科学技术研究基金 (No :0 2 110 76 13) 浙江省卫生科学研究基金 (No :2 0 0 3A0 4 3)资助
关键词 内皮祖细胞 冠状动脉疾病 Endothelial progenitor cells Coronary disease
  • 相关文献

参考文献9

  • 1[1]Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275: 964-967.
  • 2[2]Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood,2000, 95: 952-958.
  • 3[3]Walter D H, Rittig K, Bahlmann F H, et al. Statin therapy accelerate reendothelialization.Circulation, 2002, 105:3017-3024.
  • 4[4]Hill J M, Zalos G, Halcox J P, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348:593-600.
  • 5[5]Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells Inversely correlate with risk factors for coronary artery disease. Cir Res,2001, 89: E1-7.
  • 6[6]Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3422-3427.
  • 7[7]Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 2001, 103: 2885-2890.
  • 8[8]Murohara T, Tepper O, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol, 2002,30:967-967.
  • 9[9]Suzuki T, Nishida M, Futami S, et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res, 2003,58:487-492.

同被引文献18

  • 1Tu-gang CHEN Jun-zhu CHEN Xu-dong XIE.Effects of aspirin on number,activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood[J].Acta Pharmacologica Sinica,2006,27(4):430-436. 被引量:8
  • 2ISNER J, ASAHARA T. Angiogenesis and autogene- sis as therapeutic strategies for postnatal revascular-izations[J]. J Clin Invest, 1999,103 : 1231 - 1236.
  • 3ASAHARA T, MUROHARA T, SULLIVAN A, et al. Isolation of putative endothelial progenitor cells for angiogenesis[J]. Science, 1997,275 : 964- 967.
  • 4SMADJA D M, BASIRE A, AMELOT A, et al. Thrombin bound to a fibrin clot confers antigenic and haemostatic properties on endothelial progenitor cells [J]. Cellular and Molecular Medicine, 2008,12 : 975 - 968.
  • 5WOJAKOWSKI W, TENDERA M. Mobilization of bone marrow-derived progenitor cells in acute coro- nary syndromes[J]. Folia Histochem Cytobiol, 2005, 43:229-232.
  • 6SCHMIDT-LUCKE C, ROSSIG L, FICHTLSCHER- ER S,et al. Reduced number of circulating endothelial progenitor cells prediets future cardiovascular events: proof of concept for the clinical importance of endoge- nous vascular repair[J]. Culation, 2005,111: 2981 - 2987.
  • 7HARADA M, QIN Y,TAKANO H, et al. G-CSF pre-vents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in eardiomyoeytes[J]. Nat Med,2005,11 :305-311.
  • 8WERNER N, NICKENIG G. Clinical and therapeuti- cally implications of EPC biology in atherosclerosis [J]. J Cell Mol Med,2006,10:318-332.
  • 9KAWAMOTO A, MURAYAMA T, KUSANO K, et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia[J]. Circulation, 2004,110 : 1398- 1405.
  • 10PERIN E C,DOHMANN H F,BOROJEVIC R,et al. Transendoeardial, autologous bone marrow cell trans- plantation for severe, chronic ischemic heart failure [J]. Circulation, 2003,107 : 2294- 2302.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部